Status: Recruiting
The ECMOCYP (cytochromes P450 Activity) Study
Prospective open label observational study including patients requiring a tMCS (VA-ECMO or Impella® CP) or in in cardiogenic shock according to the SCAI (Society for Cardiovascular Angiography and Interventions) ESC (European Society of Cardiology) definition 41,42 and not requiring or not eligible to tMCS (ECMO, Impella®, intra-aortic balloon pump) (control group).
Participants needed: 46
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, GenevaUpdated: Oct 28, 2024Locations: 1
Eligibility criteria
Male and female patients presenting a refractory cardiogenic shock, requiring te... [+4]
Male and female patients presenting a refractory ARDS requiring veno-venous extr... [+5]